SymbyAI, the cutting-edge AI company revolutionizing research and development, has hit a major milestone. The company, founded by Ashia Livaudais, recently secured a $2.1 million seed round at a $15 million valuation. With this funding, SymbyAI is accelerating its growth, expanding its team, and focusing on deploying its AI-powered platform to enterprise clients.

Raising early-stage funding is notoriously difficult for Alabama-based startups, making SymbyAI’s success even more noteworthy. Livaudais credits gBeta (part of gener8tor) with helping lay the groundwork for the company’s early traction. The accelerator provided key introductions to initial investors and ultimately connected SymbyAI with Antler in Austin, TX—a firm that played a pivotal role in the company’s growth.

Rather than a single lead investor, the $2.1 million seed round was secured through SAFE (Simple Agreement for Future Equity) agreements with multiple valued investors, reflecting broad confidence in SymbyAI’s mission and market potential.

SymbyAI reimagines the research process by shifting from static academic papers to dynamic, interactive projects. Researchers use Symby to create workspaces that integrate papers, code, data, and experiments into a single, organized hub. The AI-powered platform automates key aspects of the research lifecycle, offering:

AI-Assisted Peer Review – SymbyAI checks editorial requirements, replicates statistical methods, and detects potential image manipulation.
AI-Enabled Method Replication – Researchers can validate their methods with AI-powered simulations and replications.
Advanced Image Analysis – The system reviews scientific assets for integrity and accuracy.
On-Demand Research Insights – Users can generate AI-driven literature reviews, data simulations, and code replications to enhance their research.

Since raising the seed round in December, SymbyAI has more than doubled its team, growing from four to nine employees. The company has added specialists, including AI research scientists and front-end and back-end developers, to strengthen its platform and meet increasing demand.

SymbyAI’s impact is already being felt across industries. While specific client names remain confidential due to strict agreements, the company serves a diverse range of organizations, including academic publishers, commercial R&D teams, and clinical research centers.

Financially, the company is on an upward trajectory. Annual recurring revenue (ARR) has grown from $450,000 at the time of the previous report to approximately $550,000, with nine signed contracts. The company’s next major milestone? Reaching $1 million in ARR by mid-year, a goal that Livaudais and her team are actively working toward.

Looking ahead, SymbyAI is focused on ensuring smooth early deployments for its enterprise clients, fine-tuning its product, and expanding its reach in the research community. With a clear mission and a rapidly growing team, the company is well-positioned to become a major player in AI-driven research and development.

“We’ve been able to assemble an incredible team that will further us down the path of creating a lean operating system for scientific discovery and validation,” says Livaudais. “We plan on continuing to build out loud, so anybody interested in following our next steps can follow SymbyAI on LinkedIn, X, and Bluesky (@SymbyLabs).”